Skip to content

Treatment of irritable bowel syndrome with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): a randomized, monocentric clinical trial on efficacy and the central mechanism of fMRI

Treatment of irritable bowel syndrome with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): a randomized, monocentric clinical trial on efficacy and the central mechanism of fMRI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014554
Enrollment
Unknown
Registered
2018-01-21
Start date
2018-03-01
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

irritable bowel syndrome

Interventions

Acupuncture group (therapy group):the auricular branch of the vagal nerve (auricular t-VNS)
Control:Fake acupuncture

Sponsors

Guangdong Provincial Hospital of TCM; the Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. meet the diagnostic criteria of Rome III IBS, colonoscopy to exclude other diseases caused by constipation, abdominal pain; 2. men and women, aged 18 to 65 years; 3. nearly two months to take IBS medication; 4. in vivo No metal implants, no claustrophobia and other MRI and other MRI contraindications; 5. with reading and writing ability and can cooperate with the examination and treatment; 6. subjects informed, voluntarily received tVNS treatment and signed informed consent. (Note: At the same time meet the above criteria included parties).

Exclusion criteria

Exclusion criteria: 1. Those who did not meet the above diagnostic criteria; 2. Anxiety scale greater than or equal to 50, as measured by Self-rating Anxiety Scale (SAS) or Self-rating Depression Scale (SDS) Or depression patients; 3. with cardiovascular and cerebrovascular, liver, kidney and hematopoietic system and other serious life-threatening primary diseases and mental patients; 4. pregnant or pregnant women, lactating women; 5. can not adhere to tVNS treatment and can not understand the amount of Table person. (Note: those who meet one or more of those who exclude).

Design outcomes

Primary

MeasureTime frame
The number of days of IBS attack /30 days;IBS specific quality of life questionnaire(IBS-QOL);Symptoms points;Regional Homogeneity (ReHo);Brain Functional Connectivity Analysis;Fanctional Network Analysis;

Countries

China

Contacts

Public ContactChen Jun

Guangdong Provincial Hospital of TCM; the Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine

296034904@qq.com+86 13711223857

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026